(828.6) Epigenome-wide association study of bronchopulmonary dysplasia (BPD) in preterm infants: Results from the Discovery-BPD program

Poster Board Number: D50

Hye-Youn Cho (National Institute of Environmental Health Sciences), Xuting Wang (National Institute of Environmental Health Sciences), Michelle Campbell (National Institute of Environmental Health Sciences), Vijayalakshmi Panduri (National Institute of Environmental Health Sciences), Silvina Coviello (Fundacion INFANT), Mauricio Caballero (Fundacion INFANT), Deepa Sambandan (National Institute of Environmental Health Sciences), Steven Kleeberger (National Institute of Environmental Health Sciences), Fernando Polack (Fundacion INFANT, Fundacion INFANT), Gaston Ofman (University of Oklahoma Health Sciences Center), Douglas Bell (National Institute of Environmental Health Sciences)

Bronchopulmonary dysplasia (BPD) is a lung disease in premature infants characterized by impaired pulmonary development which persists into later life. While advances in neonatal care have improved survival rates of premature infants, cases of BPD have been increasing with limited therapeutic options for prevention and treatment. This study was designed to explore the relationship between gestational age (GA), birth weight and estimated blood cell-type composition in premature infants and to elucidate early epigenetic biomarkers associated with BPD. Cord blood DNA from preterm neonates that went on to develop BPD (n = 14) or not (nonBPD, n = 93) was applied to Illumina 450K methylation arrays. Blood cell-type compositions were estimated using DNA methylation profiles. Multivariable robust regression analysis elucidated CpGs associated with BPD risk. cDNA microarray analysis of cord blood RNA identified differentially expressed genes in neonates who later developed BPD. The need for oxygen supplementation was strongly associated (p lt; 1.0E-09) with GA. The estimated nucleated red blood cell (NRBC) percent was negatively associated with birth weight and GA, positively associated with hypomethylation of the tobacco smoke exposure biomarker cg05575921, and high-NRBC bloods displayed a hypomethylation profile. Epigenome-wide association study (EWAS) identified 38 (Bonferroni) and 275 (false discovery rate 1%) differentially-methylated CpGs associated with BPD. BPD-associated CpGs in cord blood were enriched for lung maturation and hematopoiesis pathways. Stochastic epigenetic mutation burden was significantly elevated among those who developed BPD (adjusted p = 0.02). Methylation-based GA prediction models suggested GA acceleration in BPD. Transcriptome changes in cord blood cells reflected cell cycle, development, and pulmonary disorder events in BPD. While results must be interpreted with caution because of the small size of this study, NRBC content strongly impacted DNA methylation profiles in preterm cord blood while EWAS revealed potential insights into biological pathways involved in BPD pathogenesis.

lt;igt;Supported by the NIEHS Intramural Research Programlt;/igt;